Ultrabright fluorophores emitting in the second near-infrared (NIR-II, 1000–1700 nm) window are highly desirable for biomedical and optoelectronic applications but remain rare, because fluorescence brightness requires the simultaneous realization of a large absorption coefficient (ε) and a high photoluminescence quantum yield (Φ PL ), two parameters that are inherently difficult to balance. Here, we develop an ultrabright semiconducting polymer fluorophore (P1) via a simple noncovalent conformational locking strategy that enforces a rigid and planar backbone with small dihedral angles. This design extends π-conjugation to boost ε and Φ PL while effectively suppressing aggregation-caused quenching in P1 nanoparticles (P1 NPs). Compared to its unlocked analogue, P1 NPs exhibits a notable 360 nm redshift towards NIR-II emission, together with intensified ε and elevated Φ PL . These properties afford P1 NPs 10-fold enhancement in NIR-II brightness relative to reported polymer fluorophores, enabling high-resolution vascular imaging and precise inflammation localization. These findings represent a significant design advance in creating ultrabright fluorophores for bioimaging and optoelectronic applications.
No takes yet. Share an insight, caveat, or question.
Miao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: